Kristian Brock

(Former)

Kristian Brock

Links

ORCID: 0000-0002-3921-0166
View graph of relations

Most downloaded publications

How to design a dose-finding study using the continual reassessment method
Kristian Brock, Christina Yap, 18 Jan 2019, In : BMC Medical Research Methodology. 19, 1, 15 p., 18.

Research output: Contribution to journal › Article

159 downloads
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
Charles Craddock, Daniel Slade, Carmela De Santo, Rachel Hoare, Kristian Brock, Francis Mussai & Christina Yap, 1 Mar 2019, In : Journal of Clinical Oncology . 37, 7, p. 580-588 9 p., JCO1800889.

Research output: Contribution to journal › Article

141 downloads
Acquired Isodisomy on Chromosome 13 at diagnosis results in impaired overall survival in Patients with FLT3-ITD mutant Acute Myeloid Leukaemia
Justin Loke, Kristian Brock, Paul Ferguson, Charles Craddock & Manoj Raghavan, 2015, In : Leukemia. 29, 12, p. 2404-2407

Research output: Contribution to journal › Article

123 downloads
Recommendations for Randomised Trials in Surgical Oncology
James Glasbey, Kristian Brock & Simon Bach, Dec 2017, In : Clinical Oncology. 29, 12, p. 799-810

Research output: Contribution to journal › Article

111 downloads
Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study
Kristian Brock, Sam Munoz Vicente, Becky Boucher, 20 Oct 2019, In : Journal of Clinical Oncology . 37, 30, p. 2722-2729 8 p.

Research output: Contribution to journal › Article

111 downloads

Recent publications

CSTI-300 (SMP-100); a novel 5-HT3 receptor partial agonist with potential to treat patients with irritable bowel syndrome or carcinoid syndrome
Alexander Roberts, Gillian Grafton, Andy Powell, Kristian Brock, Alison Cooper, Omar Qureshi, Zania Stamataki & Nicholas Barnes, 1 Apr 2020, In : Journal of Pharmacology and Experimental Therapeutics. 373, 1, p. 122-134 13 p.

Research output: Contribution to journal › Article

Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial
Gary Middleton, Kristian Brock & Lucinda Billingham, 19 Mar 2020, In : The Lancet Respiratory Medicine.

Research output: Contribution to journal › Article

A Phase II Clinical Trial with Efficacy and Toxicity Outcomes and Baseline Covariates
Kristian Brock, Lucinda Billingham, Christina Yap & Gary Middleton, 27 Nov 2019, Bayesian Statistics: New Challenges and New Generations. Springer, p. 125-133 (Springer Proceedings in Mathematics & Statistics; vol. 296).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

View all (22)

Recent Activities

Dose-Finding Clinical Trial Designs in Stan

Kristian Brock (Speaker)

30 Aug 2018

Activity: Talk or presentation › Academic conference

A Phase II Clinical Trial with Efficacy and Toxicity Outcomes and Baseline Covariates

Kristian Brock (Speaker), , Lucinda Billingham (Contributor), , Gary Middleton (Contributor), & Christina Yap (Contributor)

2 Jul 2018

Activity: Talk or presentation › Academic conference

Benefits and limitations of subgroup analyses in oncology trials

Kristian Brock (Invited speaker)

4 May 2018

Activity: Talk or presentation › Invited talk

View all (21)